Jing Ji Guan Cha Wang·2026-02-20 16:48Core Insights - The core viewpoint of the article highlights Danone's financial performance for the year 2025, focusing on overall performance, regional market dynamics, and future growth guidance [1]. Financial Performance - In 2025, Danone's global sales revenue increased by 4.5%, exceeding 220 billion RMB. The company anticipates a same-store sales growth of 3% to 5% for the full year of 2026, with recurring operating profit growth expected to outpace sales revenue growth [2]. Business Development - The region is identified as a key driver of Danone's performance growth. In the fourth quarter, sales revenue grew by 10.4%, primarily driven by volume and product mix, which contributed to a growth of 10.6%. For the full year, the specialized nutrition business (including infant formula and medical nutrition) generated revenue of €2.768 billion, reflecting a year-on-year increase of 13.2%. The bottled water and beverage segment reported revenue of €777 million, up 6.1% year-on-year [3]. Recent Events - The report mentions the impact of a recent infant formula recall, stating that the financial impact is assessed to be "not significant," with an expected effect on net sales of approximately 0.5% to 1% in the first quarter of 2026. The company emphasizes that products sold through official channels in China were unaffected and is focused on rebuilding trust. Additionally, Danone has prepared an unprecedented product renewal plan for the 2026 sales season in the Chinese market, aiming to minimize inventory levels in preparation for the launch of new products [4].